
TY  - JOUR
TI  - Abstracts - Tuesday 24th July 2001
JO  - Scandinavian Journal of Immunology
VL  - 54
IS  - s1
SN  - 0300-9475
UR  - https://doi.org/10.1046/j.1365-3083.2001.0540s1002.x
DO  - doi:10.1046/j.1365-3083.2001.0540s1002.x
SP  - 2
EP  - 2
PY  - 2001
ER  - 

TY  - JOUR
TI  - ASBMR 26th Annual Meeting SU001–SU586
JO  - Journal of Bone and Mineral Research
JA  - J Bone Miner Res
VL  - 19
IS  - S1
SN  - 0884-0431
UR  - https://doi.org/10.1002/jbmr.5650191305
DO  - doi:10.1002/jbmr.5650191305
SP  - S204
EP  - S343
PY  - 2004
ER  - 

TY  - JOUR
TI  - Poster Abstracts Not Accepted For Live Presentation
JO  - Pediatric Dermatology
JA  - Pediatr Dermatol
VL  - 34
IS  - S1
SN  - 0736-8046
UR  - https://doi.org/10.1111/pde.13196
DO  - doi:10.1111/pde.13196
SP  - S100
EP  - S212
PY  - 2017
ER  - 

TY  - JOUR
TI  - Abstracts
JO  - Brain Pathology
VL  - 16
IS  - s1
SN  - 1015-6305
UR  - https://doi.org/10.1111/j.1750-3639.2006.00019.x
DO  - doi:10.1111/j.1750-3639.2006.00019.x
SP  - S1
EP  - S172
PY  - 2006
ER  - 

TY  - JOUR
TI  - International Society of Paediatric Oncology SIOP XXXXII Congress Boston, United States October 21–24, 2010 SIOP Abstracts
JO  - Pediatric Blood & Cancer
JA  - Pediatr. Blood Cancer
VL  - 55
IS  - 5
SN  - 1545-5009
UR  - https://doi.org/10.1002/pbc.22779
DO  - doi:10.1002/pbc.22779
SP  - 775
EP  - 1014
PY  - 2010
ER  - 

AU  - Popoff, Michel R.
C7  - pp. 21-43
TI  - Toxins of Histotoxic Clostridia
SN  - 9781118728406
UR  - https://doi.org/10.1002/9781118728291.ch4
DO  - doi:10.1002/9781118728291.ch4
SP  - 21-43
KW  - C. chauvoei
KW  - C. novyi
KW  - C. septicum
KW  - C. sordellii
KW  - intracellularly active toxins
KW  - large clostridial glucosylating toxin
KW  - membrane-damaging toxins
KW  - phospholipases
KW  - pore-forming toxins
PY  - 2010
AB  - Summary In animals, Clostridium chauvoei, C. novyi, C. septicum, and C. sordellii are responsible for severe toxico-infections, which result mainly from wound contamination, except for C. chauvoei which can induce the so-called endogenous myositis. These clostridia produce potent toxins that are the main virulence factors involved in the generation of lesions and clinical signs. The toxins produced by the histotoxic clostridia can be divided into two families: those which are active intracellularly, causing perturbation of epithelial and endothelial barriers and then cell necrosis; and those which are active on cell membranes, leading to the death of various cell types. The major toxins produced by C. novyi and C. sordellii belong to the large clostridial glucosylating toxin (LCGT) family. Membrane-damaging toxins encompass the pore-forming toxins (PFTs) and the toxins that enzymatically cleave membrane compounds such as phospholipases.
ER  - 

TY  - JOUR
TI  - ACR Meeting
JO  - Arthritis & Rheumatism
JA  - Arthritis & Rheumatism
VL  - 64
IS  - S10
SN  - 9781118728406
UR  - https://doi.org/10.1002/art.37735
DO  - doi:10.1002/art.37735
SP  - S1
EP  - S1216
PY  - 2012
AB  - Abstract http://acrmeeting.wiley.com/
ER  - 

TY  - JOUR
TI  - Poster Session I (Abstracts 259 – 729)
JO  - Hepatology
JA  - Hepatology
VL  - 64
IS  - S1
SN  - 9781118728406
UR  - https://doi.org/10.1002/hep.28797
DO  - doi:10.1002/hep.28797
SP  - 136
EP  - 361
PY  - 2016
ER  - 

TY  - JOUR
TI  - Poster Discussion Session PDS 1
JO  - Allergy
JA  - Allergy
VL  - 70
IS  - S101
SN  - 9781118728406
UR  - https://doi.org/10.1111/all.12717
DO  - doi:10.1111/all.12717
SP  - 113
EP  - 279
PY  - 2015
ER  - 

TY  - JOUR
TI  - Thursday, 28 July 2011
JO  - Journal of Thrombosis and Haemostasis
VL  - 9
IS  - s2
SN  - 9781118728406
UR  - https://doi.org/10.1111/j.1538-7836.2011.04380_4.x
DO  - doi:10.1111/j.1538-7836.2011.04380_4.x
SP  - 712
EP  - 959
PY  - 2011
ER  - 

TY  - JOUR
TI  - Abstracts for the XIIth World Congress of Psychiatric Genetics
JO  - American Journal of Medical Genetics Part B: Neuropsychiatric Genetics
JA  - Am. J. Med. Genet.
VL  - 130B
IS  - 1
SN  - 9781118728406
UR  - https://doi.org/10.1002/ajmg.b.30101
DO  - doi:10.1002/ajmg.b.30101
SP  - 1
EP  - 180
PY  - 2004
ER  - 

TY  - JOUR
AU  - Lim, Rebecca
TI  - Concise Review: Fetal Membranes in Regenerative Medicine: New Tricks from an Old Dog?
JO  - STEM CELLS Translational Medicine
JA  - STEM CELLS Translational Medicine
VL  - 6
IS  - 9
SN  - 9781118728406
UR  - https://doi.org/10.1002/sctm.16-0447
DO  - doi:10.1002/sctm.16-0447
SP  - 1767
EP  - 1776
KW  - Cellular therapy
KW  - Fetal stem cells
KW  - Placental stem cells
KW  - Tissue-specific stem cells
KW  - Tissue regeneration
PY  - 2017
AB  - Abstract The clinical application of the fetal membranes dates back to nearly a century. Their use has ranged from superficial skin dressings to surgical wound closure. The applications of the fetal membranes are constantly evolving, and key to this is the uncovering of multiple populations of stem and stem-like cells, each with unique properties that can be exploited for regenerative medicine. In addition to pro-angiogenic and immunomodulatory properties of the stem and stem-like cells arising from the fetal membranes, the dehydrated and/or decellularized forms of the fetal membranes have been used to support the growth and function of other cells and tissues, including adipose-derived mesenchymal stem cells. This concise review explores the biological origin of the fetal membranes, a history of their use in medicine, and recent developments in the use of fetal membranes and their derived stem and stem-like cells in regenerative medicine. Stem Cells Translational Medicine 2017;6:1767?1776
ER  - 

TY  - JOUR
TI  - Abstract
JO  - Microcirculation
JA  - Microcirculation
VL  - 22
IS  - 8
SN  - 9781118728406
UR  - https://doi.org/10.1111/micc.12212
DO  - doi:10.1111/micc.12212
SP  - 753
EP  - 781
PY  - 2015
ER  - 

TY  - JOUR
AU  - Paschos, Nikolaos K.
AU  - Brown, Wendy E.
AU  - Eswaramoorthy, Rajalakshmanan
AU  - Hu, Jerry C.
AU  - Athanasiou, Kyriacos A.
C8  - TERM-13-0351.R1
TI  - Advances in tissue engineering through stem cell-based co-culture
JO  - Journal of Tissue Engineering and Regenerative Medicine
JA  - J Tissue Eng Regen Med
VL  - 9
IS  - 5
SN  - 9781118728406
UR  - https://doi.org/10.1002/term.1870
DO  - doi:10.1002/term.1870
SP  - 488
EP  - 503
KW  - stem cells
KW  - co-culture
KW  - tissue engineering
KW  - regenerative medicine
KW  - cellular interaction
KW  - repair
KW  - direct co-culture
KW  - indirect co-culture
PY  - 2015
AB  - Abstract Stem cells are the future in tissue engineering and regeneration. In a co-culture, stem cells not only provide a target cell source with multipotent differentiation capacity, but can also act as assisting cells that promote tissue homeostasis, metabolism, growth and repair. Their incorporation into co-culture systems seems to be important in the creation of complex tissues or organs. In this review, critical aspects of stem cell use in co-culture systems are discussed. Direct and indirect co-culture methodologies used in tissue engineering are described, along with various characteristics of cellular interactions in these systems. Direct cell?cell contact, cell?extracellular matrix interaction and signalling via soluble factors are presented. The advantages of stem cell co-culture strategies and their applications in tissue engineering and regenerative medicine are portrayed through specific examples for several tissues, including orthopaedic soft tissues, bone, heart, vasculature, lung, kidney, liver and nerve. A concise review of the progress and the lessons learned are provided, with a focus on recent developments and their implications. It is hoped that knowledge developed from one tissue can be translated to other tissues. Finally, we address challenges in tissue engineering and regenerative medicine that can potentially be overcome via employing strategies for stem cell co-culture use. Copyright ? 2014 John Wiley & Sons, Ltd.
ER  - 

TY  - JOUR
C7  - e13423
TI  - Poster Sessions
JO  - Neurogastroenterology & Motility
JA  - Neurogastroenterol Motil
VL  - 30
IS  - S1
SN  - 9781118728406
UR  - https://doi.org/10.1111/nmo.13423
DO  - doi:10.1111/nmo.13423
SP  - e13423
PY  - 2018
ER  - 

TY  - JOUR
TI  - Abstracts
JO  - Basic & Clinical Pharmacology & Toxicology
JA  - Basic Clin Pharmacol Toxicol
VL  - 126
IS  - S1
SN  - 9781118728406
UR  - https://doi.org/10.1111/bcpt.13376
DO  - doi:10.1111/bcpt.13376
SP  - 10
EP  - 137
PY  - 2020
ER  - 

TY  - JOUR
TI  - Poster Session Abstracts
JO  - Pediatric Pulmonology
JA  - Pediatr Pulmonol.
VL  - 48
IS  - S36
SN  - 9781118728406
UR  - https://doi.org/10.1002/ppul.22898
DO  - doi:10.1002/ppul.22898
SP  - 207
EP  - 453
PY  - 2013
ER  - 

AU  - Harry, G. Jean
AU  - Lein, Pamela J.
C7  - pp. 193-227
TI  - Developmental Neurotoxicity of Dioxins
SN  - 9780470605295
UR  - https://doi.org/10.1002/9781118184141.ch7
DO  - doi:10.1002/9781118184141.ch7
SP  - 193-227
KW  - dioxins, developmental neurotoxicity, altering normalcy
KW  - developmental effects due to dioxin-mediated AhR crosstalk
KW  - TCDD, neurotoxicity, altered, neurogenesis
PY  - 2013
AB  - Summary This chapter contains sections titled: Introduction Epidemiological Studies on Neurodevelopmental Effects of Dioxin Mechanisms of Dioxin Toxicity Overview of Neurodevelopment in the Central Nervous System Potential for Developmental Effects Due to Dioxin-Mediated AHR Activation Experimental Studies on Molecular and Cellular Effects of TCDD in Neural Model Systems Experimental Studies of Neurobehavioral Effects of Developmental Exposure to TCDD Summary References
ER  - 

AU  - Valli, Victor E.
AU  - Bienzle, Dorothee
AU  - Meuten, Donald J.
C7  - pp. 203-321
TI  - Tumors of the Hemolymphatic System
SN  - 9780813821795
UR  - https://doi.org/10.1002/9781119181200.ch7
DO  - doi:10.1002/9781119181200.ch7
SP  - 203-321
KW  - bone marrow
KW  - cytological characteristics
KW  - hemolymphatic system
KW  - lymphoblastic tumors
KW  - molecular diagnostic tests
KW  - myeloid leukemias
KW  - neoplastic cells
KW  - veterinary medicine
PY  - 2013
AB  - Summary The two general groups for tumors of the hemolymphatic system are lymphoid (lymphoma and leukemia) and myeloid leukemias. The tumors in each can be characterized by their anatomic distribution in the body, histologic distribution within hemolymphatic organs, morphology of cells, immunophenotype, cytopenias, and, when known, their biologic behavior and molecular characteristics. Lymphoblastic tumors are some of the most aggressive neoplasms in veterinary medicine with survival times measured in weeks to months. Lymphomas arise in lymphoid tissues outside of the bone marrow and leukemias arise in bone marrow or spleen. Classification of lymphomas has progressed through criteria largely related to cytological characteristics (Kiel) to one based on distinct diseases encompassing the total information related to that neoplasm. The Kiel and WHO/REAL classifications use multiple parameters to subdivide lymphomas into many diagnoses. Molecular techniques complement these classifications and additionally further subdivide lymphomas and leukemias, demonstrating how heterogeneous phenotypically similar tumors are.
ER  - 

TY  - JOUR
TI  - Poster Presentations - Poster Session 1: Sunday, 30 August 2009 - Monday, 31 August 2009
JO  - Transplant International
VL  - 22
IS  - s2
SN  - 9780813821795
UR  - https://doi.org/10.1111/j.1432-2277.2009.00958.x
DO  - doi:10.1111/j.1432-2277.2009.00958.x
SP  - 95
EP  - 222
PY  - 2009
ER  - 
